Genesis Receives National Stroke Award
Demonstrates Commitment to Providing Quality Stroke Treatment
ZANESVILLE, OH (Aug. 24, 2017) – Genesis HealthCare System received the American Heart Association/American Stroke Association’s (AHA/ASA) Get With The Guidelines®-Stroke Gold Plus Quality Achievement Award with Target: StrokeSM Honor Roll. The award recognizes the hospital’s commitment to providing the most appropriate stroke treatment according to nationally recognized research guidelines based on the latest scientific evidence. This is the third consecutive year for the Stroke Gold Plus Quality Achievement Award and the second consecutive year Genesis has received the award together with the Target: Stroke Honor Roll.
“Our team is proud to receive the award again because it shows we are providing quality stroke care to the people of our community,” said Keela Barker, director, Genesis Rehabilitation Services.
“We continue to strive for excellence in the acute treatment of stroke patients, where every minute that treatment is delayed can alter a patient’s life,” said Bryan Bjornstad, M.D., neurologist and medical director of the Genesis stroke program. “This recognition demonstrates our commitment to delivering advanced stroke treatments to patients quickly and safely.”
Hospitals must achieve 85 percent or higher adherence to all Get With The Guidelines-Stroke achievement indicators for two or more consecutive 12-month periods and achieve 75 percent or higher compliance with five of eight Get With The Guidelines-Stroke Quality measures to receive the Gold Plus Quality Achievement Award.
Genesis has also met specific scientific guidelines as a Primary Stroke Center, featuring a comprehensive system for rapid diagnosis and treatment of stroke patients admitted to the Emergency Department.
To qualify for the Target: Stroke Honor Roll, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke. If given intravenously in the first three hours after the start of stroke symptoms, tPA has been shown to significantly reduce the effects of stroke and lessen the chance of permanent disability. Genesis earned the award by meeting specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period.
Get With The Guidelines-Stroke puts the expertise of the AHA/ASA to work for hospitals nationwide, helping hospital care teams ensure the care provided to patients is aligned with the latest research-based guidelines. Developed with the goal to save lives and improve recovery time, Get With The Guidelines®-Stroke has impacted more than 3 million patients since 2003.
According to the American Heart Association/American Stroke Association, stroke is the No. 5 cause of death and a leading cause of adult disability in the United States. On average, someone in the U.S. suffers a stroke every 40 seconds; someone dies of a stroke every four minutes; and nearly 800,000 people suffer a new or recurrent stroke each year.